glp 1 kidney disease GLP-1 Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists SGLT2 Inhibitors and GLP-1 Receptor

For example, liraglutide might reduce the occurrence rate of myocardial infarction in high-risk T2DM patients and enhance the clinical outcomes of myocardial infarction (28)

doi: 10.1186/s12933-021-01386-4

The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice

Safety: GI events remain the class effect

Drug (vaccine)-induced thrombocytopenia 2021: diversity of pathogenesis and clinical features

There are many reasons that people stop these medications, including side effects, lack of medication availability, achievement of targeted weight loss, and insurance difficulties or inability to afford out-of-pocket costs